Inflammatory signals induce neurotrophin expression in human microglial cells

Journal of Neurochemistry

Volumn 70, Issue 2, 1998, Pages 699-707

  Heese, Klaus ^a   Hock, Christoph ^a   Otten, Uwe ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Alzheimer's disease; Complement factors; Cytokines; Nerve growth factor

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; COMPLEMENT COMPONENT C3A; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; MICROGLIA; NERVE CELL CULTURE; NERVE CELL DEGENERATION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031913982     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70020699.x     Document Type: Article

References (65)

1. Araujo D. M. and Cotman C. W. (1992) Basic FGF in astroglial, microglial, and neuronal cultures: characterization of binding sites and modulation of release by lymphokines and trophic factors. J. Neurosci. 12, 1668-1678.
2. Baeuerle P. A. and Baltimore D. (1996) NF-κB: ten years after. Cell 87, 13-20.
3. Banati R. B., Gehrmann J., Schubert B., and Kreutzberg G. W. (1993) Cytotoxicity of microglia. Glia 7, 111-118.
4. Banati R. B., Gehrmann J., Lannes-Vieira J., Wekerle H., and Kreutzberg G. W. (1995) Inflammatory reaction in experimental autoimmune encephalomyelitis (EAE) is accompanied by a microglial expression of the βA4-amyloid precursor protein (APP). Glia 14, 209-215.
5. Barnes P. J. and Karin M. (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336, 1066-1071.
6. Bauer M. K. A., Lieb K., Schulze-Osthoff K., Berger M., Gebicke-Haerter P. J., Bauer J., and Fiebich B. L. (1997) Expression and regulation of cyclooxygenase-2 in rat microglia. Eur. J. Biochem. 243, 726-731.
7. Boland K., Behrens M., Choi D., Manias K., and Perlmutter D. H. (1996) The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide. J. Biol. Chem. 271, 18032-18044.
8. Bürgi B., Otten U. H., Ochsenberger B., Rihs S., Heese K., Ehrhard B. P., Ibanez C. F., and Dahinden C. A. (1996) Basophil priming by neurotrophic factors. J. Immunol. 157, 5582-5588.
9. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
10. Cotman C. W., Pike C. J., and Copani A. (1992) β-Amyloid neurotoxicity: a discussion of in vitro findings. Neurobiol. Aging 13, 587-590.
11. Davies E. J., Foster T. D., and Thomas W. E. (1994) Cellular forms and functions of brain microglia. Brain Res. Bull. 34, 73-78.
12. Del Bo R., Angeretti N., Lucca E., De Simoni M. G., and Forloni G. (1995) Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neurosci. Lett. 188, 70-74.
13. Dickson D. W., Lee S. C., Mattiace L. A., Yen S. H., and Brosnan C. (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7, 75-83.
14. Ehrhard P. B., Erb P., Graumann U., and Otten U. (1993a) Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. USA 90, 10984-10988.
15. Ehrhard P. B., Ganter U., Bauer J., and Otten U. (1993b) Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA 90, 5423-5427.
16. Eikelenboom P., Hack C. E., Rozemuller J. M., and Stam F. C. (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. B Cell Pathol. 56, 259-262.
17. Elkabes S., DiCicco-Bloom E. M., and Black I. B. (1996) Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J. Neurosci. 16, 2508-2521.
18. El Khoury J., Hickmann S. E., Thomas C. A., Cao L., Silverstein S. C., and Loike J. D. (1996) Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils. Nature 382, 716-719.
19. Gadient R. A., Cron C., and Otten U. (1990) Interleukin-1β and tumor necrosis factor-α synergistically stimulate nerve growth factor release from cultured astrocytes. Neurosci. Lett. 117, 335-340.
20. Gall C., Murray K., and Isackson P. J. (1991) Kainic acid-induced seizures stimulate increased expression of nerve growth factor mRNA in rat hippocampus. Mol. Brain Res. 9, 113-123.
21. Giulian D. (1992) Microglia and disease of the nervous system. Curr. Neurol. 12, 23-54.
22. Giulian D., Vaca K., and Noonan C. A. (1990) Secretion of neurotoxins by mononuclear phagocytes infected with HIV-1. Science 250, 1593-1596.
23. Giulian D., Haverkamp L. J., Li J., Karshin W. L., Yu J., Tom D., Li X., and Kirkpatrick J. B. (1995) Senile plaque stimulates microglia to release a neurotoxin found in Alzheimer's brain. Neurochem. Int. 27, 119-137.
24. Giulian D., Haverkamp L. J., Yu J. H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo Y.-M., and Roher A. E. (1996) Specific domains of β-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16, 6021-6037.
25. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L. 3rd, and Aroz C. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer's disease. Proc. Natl. Acad. Sci. USA 86, 7611-7615.
26. Haga S., Ikeda K., Sato M., and Ishii T. (1993) Synthetic Alzheimer amyloid β/A4 peptides enhance production of complement C3 component by cultured microglial cells. Brain Res. 601, 88-94.
27. Henco K. and Heibey M. (1990) Quantitative PCR: the determination of template copy numbers by temperature gradient gel electrophoresis (TGGE). Nucleic Acids Res. 18, 6733-6734.
28. Henkel T., Machleidt T., Alkalay I., Krönke M., Ben-Neriah Y., and Baeuerle P. A. (1993) Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365, 182-185.
29. Janabi N., Peudenier S., Héron B., Heng Ng K., and Tardieu M. (1995) Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen. Neurosci. Lett. 195, 105-108.
30. Kaltschmidt B., Uherek M., Volk B., Baeuerle P. A., and Kaltschmidt C. (1997) Transcription factor NF-κB is activated in primary neurons by amyloid peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 2642-2647.
31. Kaltschmidt C., Kaltschmidt B., Lannes-Vieira J., Kreutzberg G. W., Wekerle H., Baeuerle P. A., and Gehrmann J. (1994) Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 55, 99-106.
32. Kreutzberg G. W. (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19, 312-318.
33. Kreutzberg G. W., Graeber M. B., and Streit W. (1986) Neuronglia relationship during regeneration of motoneurons. Metab. Brain Dis. 4, 81-85.
34. Levi-Montalcini R. (1987) The nerve growth factor 35 years later. Science 237, 1154-1162.
35. Levi-Montalcini R. and Calissano P. (1986) Nerve growth factor as a paradigm for polypeptide growth factors. Trends Neurosci. 9, 473-477.
36. Mallat M. and Chamak B. (1994) Brain macrophages: neurotoxic or neurotrophic effector cells? J. Leukocyte Biol. 56, 416-422.
37. Mallat M., Houlgatte R., Brachet P., and Prochiantz A. (1989) Lipopolysaccharide-stimulated rat brain macrophages release NGF in vitro. Dev. Biol. 133, 309-311.
38. Marty S., Dusart I., and Peschanski M. (1991) Glial changes following an excitotoxic lesion in the CNS. I. Microglia/macrophages. Neuroscience 45, 529-539.
39. McDonald D. R., Brunden K. R., and Landreth G. E. (1997) Amyloid fibrils activate tyrosine kinase-dependent signaling and superoxide production in microglia. J. Neurosci. 17, 2284-2294.
40. McGeer P. L. and McGeer E. G. (1995) The inflammatory response system of the brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21, 195-218.
41. McGeer P. L., Itagaki S., Tago H., and McGeer E. G. (1987) Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci. Lett. 79, 195-200.
42. McGeer P. L., Kawamata T., Walker D. G., Akiyama H., Tooyama I., and McGeer E. G. (1993) Microglia in degenerative neurological disease. Glia 7, 84-92.
43. Meda L., Cassatella M. A., Szendrei G. I., Otvos L. Jr., Baron P., Villalba M., Ferrari D., and Rossi F. (1995) Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 374, 647-650.
44. Meda L., Bernasconi S., Bonaiuto C., Sozzani S., Zhou D., Otvos L. Jr., Mantovani A., Rossi F., and Cassatella A. M. (1996) β-Amyloid (25-35) peptide and IFN-γ synergistically induce the production of the chemotactic cytokine MCP-1/JE in monocytes and microglial cells. J. Immunol. 155, 1213-1218.
45. O'Neill L. A. J. and Kaltschmidt K. (1997) NF-κB: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 20, 252-258.
46. Otten U. and Gadient R. A. (1995) Neurotrophins and cytokines - intermediaries between the immune and nervous systems. Int. J. Dev. Neurosci. 13, 147-151.
47. Otten U., Weskamp G., Hardung M., and Meyer D. K. (1987) Synthesis and release of nerve growth factor by rat macrophages. Soc. Neurosci. Abstr. 13, 184.
48. Otten U., Scully J. L., Ehrhard P. B., and Gadient R. A. (1994) Neurotrophins: signals between the nervous and immune systems. Prog. Brain Res. 103, 293-305.
49. Paresce D. M., Ghosh R. N., and Maxfield F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid β-protein via a scavenger receptor. Neuron 17, 553-565.
50. Pike C. J., Walencewicz-Wassermann A. J., Kosmoski J., Cribbs D. H., Glabe C. G., and Cotman C. W. (1995) Structure-activity analyses of β-amyloid peptides: contributions of the β25-35 region to aggregation and neurotoxicity. J. Neurochem. 64, 253-265.
51. Price T., Aitken J., and Simpson E. R. (1992) Relative expression of aromatase cytochrome P450 in human fetal tissues as determined by competitive polymerase chain reaction amplification. J. Clin. Endocrinol. Metab. 74, 879-883.
52. Schreck R., Meier B., Männel D. N., Droge W., and Baeuerle P. A. (1992) Dithiocarbamates as potent inhibitors of nuclear factor γB activation in intact cells. J. Exp. Med. 175, 1181-1194.
53. Scully J. L. and Otten U. (1993) Glucocorticoid modulation of neurotrophin expression in immortalized mouse hippocampal neurons. Neurosci. Lett. 155, 11-14.
54. Shimojo M., Nakajima K., Takei N., Hamanoue M., and Kohsaka S. (1991) Production of basic fibroblast growth factor in cultured brain microglia. Neurosci. Lett. 123, 229-231.
55. Strauss S., Otten U., Joggerst B., Plüss K., and Volk B. (1994) Increased levels of nerve growth factor (NGF) protein and mRNA and reactive gliosis following kainic acid injection into the rat striatum. Neurosci. Lett. 168, 193-196.
56. Sun S. C., Ganchi P. A., Ballard D. W., and Greene W. C. (1993) NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259, 1912-1915.
57. Thanos S., Mey J., and Wild M. (1993) Treatment of rat retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13, 455-466.
58. Thoenen H. and Barde Y.-A. (1980) Physiology of nerve growth factor. Trends Neurosci. 60, 1284-1335.
59. Thomas W. E. (1992) Brain macrophages: evaluation of microglia and their functions. Brain Res. Rev. 17, 61-74.
60. Überla K., Platzer C., Diamantstein T., and Blankenstein T. (1991) Generation of competitor DNA fragments for quantitative PCR. PCR Methods Appl. 1, 136-139.
61. Vanden Heuval J., Tyson F., and Bell D. (1993) Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques 14, 395-398.
62. Walker D. G., Kim S. U., and McGeer P. L. (1995) Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40, 478-493.
63. Weskamp G. and Otten U. (1987) An enzyme-linked immunoassay for nerve growth factor (NGF): a tool for studying regulatory mechanisms involved in NGF production in brain and peripheral tissues. J. Neurochem. 48, 1779-1786.
64. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., and Schmidt A. M. (1996) RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691.
65. Zhou N.-M., Matthys P., Polacek C., Fiten P., Sato A., Billiau A., and Froyen G. (1997) A competitive RT-PCR method for the quantitative analysis of cytokine mRNA in mouse tissues. Cytokine 9, 212-218.